| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d12fcf94a35348198bf31558dcff2cf6 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 |
| filingDate |
2000-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd9ef25c0cd976abff70ca477c9980cd |
| publicationDate |
2001-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6207366-B1 |
| titleOfInvention |
Chronic fatigue syndrome diagnosis |
| abstract |
Chronic fatigue syndrome is diagnosed through quantification of low and high molecular weight forms of RNase L in cellular extracts of RNase L-containing cells such as peripheral blood mononuclear cells. A ratio of low to high molecular weight RNase L of more than 0.15 is characteristic of chronic fatigue syndrome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7736593-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005059163-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003017493-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8632740-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011091990-A1 |
| priorityDate |
1999-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |